Fish oil (SMOFlipid) and olive oil lipid (clinoleic) in very preterm neonates

Journal of Pediatric Gastroenterology and Nutrition

Volumn 58, Issue 2, 2014, Pages 177-182

  Deshpande, Girish ^a   Simmer, Karen ^a   Deshmukh, Mangesh ^a   Mori, Trevor A ^b   Croft, Kevin D ^b   Kristensen, Judy ^a  

^a KING EDWARD MEMORIAL HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

intravenous; isoprostanes; lipid emulsions; parenteral nutrition; premature infants

Indexed keywords

ALPHA TOCOPHEROL; CLINOLEIC; COCONUT OIL; DOCOSAHEXAENOIC ACID; FISH OIL; ICOSAPENTAENOIC ACID; ISOPROSTANE DERIVATIVE; LINOLEIC ACID; LIPID EMULSION; OLEIC ACID; OLIVE OIL; SOYBEAN OIL; UNSATURATED FATTY ACID; VEGETABLE OIL;

BLOOD; CHEMISTRY; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECTS; FEMALE; HUMAN; LIPID PEROXIDATION; MALE; NEWBORN; OXIDATIVE STRESS; PREMATURITY; RANDOMIZED CONTROLLED TRIAL; TOTAL PARENTERAL NUTRITION;

DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; F2-ISOPROSTANES; FAT EMULSIONS, INTRAVENOUS; FATTY ACIDS, UNSATURATED; FEMALE; FISH OILS; HUMANS; INFANT, EXTREMELY PREMATURE; INFANT, NEWBORN; LINOLEIC ACID; LIPID PEROXIDATION; MALE; OLEIC ACID; OXIDATIVE STRESS; PARENTERAL NUTRITION, TOTAL; PLANT OILS; SOYBEAN OIL; VITAMIN E;

EID: 84894100992     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0000000000000174     Document Type: Article

References (35)

1. Embleton N, Pang N, Cooke R. Postnatal malnutrition and growth retardation: an inevitable consequence of current recommendations in preterm infants? Pediatrics 2001;107:270-3.
2. Uauy R, Hoffman DR, Peirano P, et al. Essential fatty acids invisual and brain development. Lipids 2001;36:885-95.
3. Yaqoob P. Fatty acids and the immune system: from basic science to clinical applications. Proc Nutr Soc 2004;63:89-104.
4. Deshpande G, Simmer K, Mori T, et al. Efficacy and safety of an olive oil compared with soybean oil based lipid emulsion in very preterm <28 weeks) infants-a randomised controlled trial. J Pediatr Gastro-enterol Nutr 2009; 49: 619-25.
5. Webb AN, Hardy P, Peterkin M, et al. Tolerability and safety of olive oil-based lipid emulsion in critically ill neonates: a blinded randomized trial. Nutrition 2008;24:1057-64.
6. Adolph M. Lipid emulsions in parenteral nutrition-state of the art and future perspectives. Clin Nutr 2001;20 (suppl 4):14-24.
7. Koletzko B. Parenteral lipid infusion in infancy: physiology basis and clinical relevance. Clin Nutr 2002;21:53-6.
8. Waitzberg DL, Torrinhas RS, Jacintho TM. New parenteral lipid emulsion for clinical use. J Parenter Enteral Nutr 2006;30:351-67.
9. Krohn K, Koletzko B. Parenteral lipid emulsions in paediatrics. Curr Opin Clin Nutr Metab Care 2006;9:319-23.
10. Varsila E, Hallman M, Andersson S. Free-radical-induced lipid peroxi-dation during the early neonatal period. Acta Paediatr 1994;83:692-5.
11. Saugstad OD. Oxidative stress in the newborn-a 30 year prospective. Biol Neonate 2005;88:228-36.
12. Uauy R, Mena P, Wegher B, et al. Long chain polyunsaturated fatty acid formation in neonates: effect of gestational age and intrauterine growth. Pediatr Res 2000;47:127-35.
13. Buchman A. Total parenteral nutrition-associated liver disease. J Par-enter Enteral Nutr 2006;26 (5 suppl):S43-8.
14. Ginn-Pease ME, Pantalos D, King DR. TPN-associated hyperbilirubi-nemia: a common problem in newborn surgical patients. J Pediatr Surg 1985;20:436-9.
15. Grimm H, Mertes N, Goeters C, et al. Improved fatty acid and leukotriene pattern with a novel lipid emulsion in surgical patients. Eur J Nutr 2006;45:55-60.
16. Wanten GJ, Calder PC. Immune modulation by parenteral lipid emulsions. Am J Clin Nutr 2007;85:1171-84.
17. Mori TA, Burke V, Puddey IB, et al. Purified eicosapentaenoic acid and docosahexaenoic acid have differential effects of on serum lipids and lipoproteins, LDL-particle size, glucose and insulin, in mildly hyper-lipidaemic men. Am J Clin Nutr 2000;71:1085-94.
18. Mori TA, Croft KD, Puddey IB, et al. An improved method for the measurement of urinary and plasma F2-isoprostanes using gas chro-matography-mass spectrometry. Anal Biochem 1999;268:117-25.
19. Deckelbaum R. Intravenous lipid emulsion time for change. J Pediatr Gastroenterol Nutr 2003;37:112-4.
20. Roggero P, Mosca F, Gianǹi ML, et al. F2-isoprostanes and total radical-trapping antioxidant potential in preterm infants receiving parenteral lipid emulsions. Nutrition 2010;26:551-5.
21. Lynch SM, Morrow JD, Roberts LJ 2nd et al. Formation of non-cyclooxygenase derived prostanoids (F2isoprostanes) in plasma and low density lipoprotein exposed to oxidative stress invitro. J Clin Invest Med 1994;93:998-1004.
22. Musiek ES, Yin H, Milne GL, et al. Recent advances in the biochemistry and clinical relevance of the isoprostane pathway. Lipids 2005;40:987-94.
23. Milne GL, Musiek ES, Morrow JD. F2-isoprostanes as markers of oxida-tive stress in vivo: an overview. Biomarkers 2005;10 (suppl 1):S10-23.
24. Barden AE, Mori TA, Dunstan JA, et al. Fish oil supplementation in pregnancy lowers F2-isoprostanes in neonates at high risk of atopy. Free Radic Res 2004;38:233-9.
25. Tomsits E, Pataki M, Tölgyesi A, et al. Safety and efficacy of a lipid emulsion containing a mixture of soybean oil, medium-chain triglycer-ides, olive oil, and fish oil: a randomised, double-blind clinical trial in premature infants requiring parenteral nutrition. J Pediatr Gastroenterol Nutr 2010;51:514-21.
26. Skouroliakou M, Konstantinou D, Koutri K, et al. A double-blind, randomized clinical trial of the effect of omega-3 fatty acids on the oxidative stress of preterm neonates fed through parenteral nutrition. Eur J Clin Nutr 2010;64:940-7.
27. Debier C. Vitamin E during pre-and postnatal periods. Vitam Horm 2007;76:357-73.
28. Kositamongkol S, Suthutvoravut U, Chongviriyaphan N, et al. Vitamin A and E status in very low birth weight infants. J Perinatol 2011;31: 471-6.
29. Schade I, Rohm KD, Schellhaass A, et al. Inflammatory response in patients requiring parenteral nutrition: comparison of a new fish-oil-containing emulsion (SMOF) versus an olive/soybean oil-based formula. Critical Care 2008;12 (suppl 2)p144doi:10.1186/cc6365.
30. Diamond IR, Sterescu A, Pencharz PB, et al. Changing the paradigm: omegaven for the treatment of liver failure in pediatric short bowel syndrome. J Pediatr Gastroenterol Nutr 2009;48:209-15.
31. Rollins MD, Scaife ER, Jackson WD, et al. Elimination of soybean lipid emulsion in parenteral nutrition and supplementation with enteral fish oil improve cholestasis in infants with short bowel syndrome. Nutr Clin Pract 2010;25:199-204.
32. Gura KM, Lee S, Valim C, et al. Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease. Pediatrics 2008;121:678-86.
33. McNamara RK, Carlson SE. Role of omega-3 fatty acids in brain development and function and function: Potential implication for pathogenesis and prevention of psychopathology. Prostagklandians Leukot Essent Fatty Acids 2006;75:329-49.
34. Clandinin MT, Chappell JE, Leong S, et al. Intrauterine fatty acid accretion rates in human brain: implications for fatty acid requirements. Early Hum Dev 1980;4:121-9.
35. Makrides M, Gibson RA, McPhee AJ, et al. Neurodevelopmental outcomes of preterm infants fed high-dose docosahexaenoic acid: a randomized controlled trial. JAMA 2009;301:175-82.